High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus

Lupus

Volumn 7, Issue 2, 1998, Pages 113-118

  Perniok, A ^a,c   Wedekind, F ^a   Herrmann, M ^b   Specker, C ^a   Schneider, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Apoptosis; Autoantigens; Lymphocytes; SLE; Tolerance

Indexed keywords

AUTOANTIGEN; CORTICOSTEROID; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; T LYMPHOCYTE;

ACTIVITIES OF DAILY LIVING; ADRENAL CORTEX HORMONES; ANNEXIN A5; ANTIGENS, CD19; ANTIGENS, CD3; APOPTOSIS; B-LYMPHOCYTES; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; VASCULITIS;

EID: 0031884870     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678919804     Document Type: Article

References (23)

1. Rosen A, Casciola-Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995; 181: 1557-1561.
2. Casciol-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996; 93: 1624-1629.
3. Ren Y, Silverstein CL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995; 181: 1857-1862.
4. Sambrano GR, Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA 1995; 92: 1396-1400.
5. Dini L et al. Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci 1995; 108: 967-973.
6. Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol 1992; 52: 269-273.
7. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994; 37: 1415-1420.
8. Rose LM, Latchman, DS, Isenberg DA. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: a review. Br J Rheumatol 1997; 36: 158-163.
9. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproli-ferative disorder associated with autoimmunity. N Engl J Med 1996; 335: 1643-1649.
10. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996; 98: 1107-1113.
11. Mysler E et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994; 93: 1029-1034.
12. Cheng J et al. Protection of fas-mediated apoptosis by a soluble form of the fas molecule. Science. 1994; 263: 1759-1762.
13. Aringer M et al. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1423-1430.
14. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685-3692.
15. Lorenz HM et al. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997; 40: 306-317.
16. Herrmann M, Zoller OM, Hagenhofer M, Voll J, Kalden JR. Macrophages from SLE patients have a reduced capacity to engulf apoptotic cells. Arthritis Rheum 1996; 39(Suppl.): (abstract 698).
17. Mevorach D, Song X, Elkon KB. Decreased phagocytosis of apoptotic cells in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39 (SLE). (Suppl.): (abstract 697).
18. Tan EM, Cohen AS, Fries FJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
19. Liang MH, Socher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988; 31: 817-825.
20. Jennette JC et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1993; 36: 187-192.
21. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger CA. A novel assay for apoptosis. Flow cytometric detection of phosphati-dylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
22. Koopman G et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 1994; 84: 1415-1420.
23. Boersma AW, Nooter K, Oostrum RG, Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled Annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 1996; 24: 123-130.